Relief Therapeutics Holding AG (RLFTF)

[tcm55]

Looks like GEM wants NRLA, IMO.
<$.30 a share now so 10 rs to 1 makes 320M @<$3.00. 1 NRLA for 3 shares RLF then makes <$10, the deal price for NRXP.
Their S4 discussed BRPA share exchange but i Guess they BRPA will get 50M shares + the 50M (+100M) for NRX to become NRXP and then the RLF 100M = 300M as NRLA @ $10+-. NRXP wont happen without RLF-100 (100% Patent control and RLF-100 EUA), IMO.
The Crown JEWEL IS THE RLF-100 PATENT, IMO.
GEM wants a success story for their Investments, certainly NOT bickering stupidity that may decrease Values, IMO. They probably don't want to fund competitions in Logistics, manufacturing and possibly sales areas, IMO. They MAY want a Big Splash and liquidity, IMO. ASAP, IMO.
EOP2 / EOP3 meetings with the FDA should be getting set for review of RLF-100/Aviptadil/Zyemini, IMO. Brand Name does NOT MATTER, IMO. The Clinical Trial DRUG is RLF-100, given Intravenously, IMO.

Inhaler results will come after RLF-100 EUA and as NRLA happens, That's My LONG Bet. I dont see NO Box...GLTA...